FDA could soon authorize Pfizer COVID-19 booster shots for all adults

The committee has a meeting scheduled for Friday to discuss the booster dose, according to The Times.

The CDC didn’t immediately respond to a request for comment.

In September, the FDAapproved Pfizer’s COVID-19 booster shotfor adults who are 65 and older or at-risk.

The CDC thenapproved Pfizer’s booster shotfor those Americans.

Last week,Pfizer asked the FDA for approval of its booster shotfor anyone 18 and older.

Multiple studies show that vaccine effectiveness could start to drop after six to eight months.

Recent studies say a booster dose of Pfizershows 95.6% vaccine efficacyagainst COVID-19.

TheCOVID-19 vaccines are highly effectiveat preventing hospitalizationand deaths.

Over58% of the US population is fully vaccinatedagainst COVID-19, according to the CDC.